#ESGCD

Wiep Klaas Smits (ExpBac/CMAT)

@smitslab.bsky.social

3 months ago

Cartoon explaining why antibiotic treatment is a risk factor for CDI.

November is #CdiffAwarenessMonth. Amazing work by @lizahaart.bsky.social turned my idea into a cartoon to help explain why antibiotics are a risk factor for #CDI. More to come! The English version is supported by the #ESGCD (@escmid.bsky.social). Let me know if you think these cartoons are useful!

Wiep Klaas Smits (ExpBac/CMAT)

@smitslab.bsky.social

6 months ago

Counting down to the #ESGCD webinar on #AMR of #Cdiff with contributions from Jane Freeman (U Leeds, UK), Taryn Eubank (U Houston, USA), Curtis Donskey (Cleveland VA Medical Center) and Andrea Brenciani (UnivPM, Italy) - Sept 30, 15-16h CET. Free to attend via us06web.zoom.us/j/8252782643...

Wiep Klaas Smits (ExpBac/CMAT)

@smitslab.bsky.social

1 year ago

ESGCD Learn more about the ESCMID Study Group for Clostridioides difficile (ESGCD), including objectives, activities, resources, leadership and more.

Tomorrow Jan 21st is the fourth @escmid.bsky.social #ESGCD webinar of this season, this time on the topic of Policies for FMT with profs. Maria Vehreschild and Paul Feuerstadt. Go to www.escmid.org/esgcd/ and check under Webinars for details (time: 15-16 CET).

Wiep Klaas Smits (ExpBac/CMAT)

@smitslab.bsky.social

1 year ago

Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobials Objectives Increasing resistance to antimicrobials used for the treatment of Clostridioides difficile infections necessitates reproducible antimicrobial susceptibility testing. Current guidelines take...

Important new preprint from the lab with Jane Freeman (Leeds), and supported by @ESCMID #ESGCD - how to improve inter-laboratory #AST for #Cdiff: www.biorxiv.org/content/10.1...